Scientists from Yale and other institutions have discovered that tirzepatide, a drug approved to treat type 2 diabetes, may also be highly effective...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A study published in...

Diabetes drug canagliflozin benefits patients of all ages. While SGLT2 inhibitors are known to reduce the risk of heart and kidney problems in...

People with type 2 diabetes are at a high risk of developing severe health complications such as heart attacks, strokes, heart failure, and advanced...

THURSDAY, Oct. 31, 2024 -- For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is...

Bilingualism, or the ability to speak two languages, has long been recognized for its cognitive benefits, especially for older adults. Researchers...

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight patients with chronic...

Cardiovascular disease (CVD) is the top cause of death worldwide. A common type of CVD is atherosclerosis, where fat and other substances form plaques...

Exploring heart and kidney health benefits of anti-diabetic treatment canagliflozin in older adults, focusing on improved outcomes and safety...